Medical News - Keywords: CANCER, CHEMOTHERAPY, ASSAYS
A new technology assessment from ASCO states that the use of chemotherapy sensitivity and resistance assays (CSRAs) to select chemotherapeutic agents for cancer patients should not be undertaken outside of the clinical trial setting.
Article from newswise
Posted by gruwell at August 3, 2004 4:16 PM